Insider Shareholders with Direct Ownership of Tarsus Pharmaceuticals, Inc. (TARS)
This section provides a comprehensive overview of the insiders with direct ownership of Tarsus Pharmaceuticals, Inc. (TARS). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Tarsus Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Vivo Capital Ix, Llc
> 10% Shareholder |
3,245,035 | 0 | 3,245,035 $130 Million | 1 |
Oct 20, 2020
Added 7.15%
|
|
Horowitz Limited Partnership Viii
> 10% Shareholder |
1,920,933 | 0 | 1,920,933 $77.1 Million | 1 |
Oct 20, 2020
Added 8.08%
|
|
Frazier Life Sciences Ix, L.P.
> 10% Shareholder |
1,917,157 | 0 | 1,917,157 $77 Million | 1 |
Oct 20, 2020
Added 14.02%
|
|
Michael Ackermann
Director |
71,699 | 29,165 | 1,208,273 $48.5 Million | 12 |
Jun 15, 2022
Added 0.35%
|
|
William J Phd Link
Director |
35,816 | 0 | 170,448 $6.85 Million | 4 |
Jun 13, 2025
Added 1.93%
|
|
Seshadri Neervannan
Chief Operating Officer |
39,606 | 14,700 | 79,682 $3.2 Million | 13 |
Mar 20, 2025
Reduced 2.97%
|
|
Bobak R. Azamian
President/CEO and Board Chair |
92,718 | 39,083 | 53,635 $2.15 Million | 14 |
Mar 20, 2025
Reduced 13.73%
|
|
Bryan Wahl
General Counsel |
70,212 | 28,090 | 51,712 $2.08 Million | 19 |
Mar 20, 2025
Reduced 5.63%
|
|
Aziz Mottiwala
Chief Commercial Officer |
50,816 | 59,535 | 47,557 $1.91 Million | 26 |
Jun 09, 2025
Reduced 26.9%
|
|
Dianne C. Whitfield
Chief Human Resources Officer |
69,229 | 24,847 | 46,355 $1.86 Million | 19 |
Mar 20, 2025
Reduced 4.41%
|
|
Jeffrey S Farrow
Officer |
63,781 | 27,777 | 36,704 $1.47 Million | 8 |
Jun 17, 2025
Reduced 27.05%
|
|
Leonard M. Greenstein
Chief Financial Officer |
4,462 | 46,966 | 26,785 $1.08 Million | 15 |
Apr 20, 2023
Reduced 15.73%
|
|
Andrew D. Goldberg
Director |
16,700 | 0 | 16,700 $670,672 | 5 |
Jun 13, 2025
Added 16.71%
|
|
Wendy L Yarno
Director |
13,700 | 0 | 13,700 $550,192 | 4 |
Jun 13, 2025
Added 19.65%
|
|
Bhaskar Chaudhuri
Director |
8,700 | 0 | 8,700 $349,391 | 3 |
Jun 13, 2025
Added 27.8%
|
|
Elizabeth Yeu Lin
Chief Medical Officer |
8,700 | 1,006 | 7,694 $308,991 | 4 |
Jun 16, 2025
Reduced 11.56%
|
|
Rosemary A Crane
Director |
5,350 | 0 | 5,350 $214,855 | 2 |
Jun 24, 2024
Added 38.51%
|
|
Scott W Morrison
Director |
9,366 | 6,016 | 3,350 $134,536 | 5 |
Jun 13, 2025
Added 50.0%
|
|
Mark J. Holdbrook
V.P., Clinical Affairs |
2,653 | 573 | 3,191 $128,150 | 4 |
Mar 20, 2023
Reduced 5.84%
|
|
Jose M. Trevejo
CHIEF MEDICAL OFFICER |
7,549 | 6,902 | 2,251 $90,400 | 9 |
Dec 20, 2023
Reduced 50.01%
|